NO20010651L - Inhibering av type 3 3<alfa>-hydroxysteroiddehydrogenase - Google Patents
Inhibering av type 3 3<alfa>-hydroxysteroiddehydrogenaseInfo
- Publication number
- NO20010651L NO20010651L NO20010651A NO20010651A NO20010651L NO 20010651 L NO20010651 L NO 20010651L NO 20010651 A NO20010651 A NO 20010651A NO 20010651 A NO20010651 A NO 20010651A NO 20010651 L NO20010651 L NO 20010651L
- Authority
- NO
- Norway
- Prior art keywords
- type
- hydroxysteroid dehydrogenase
- inhibition
- alpha
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9562398P | 1998-08-07 | 1998-08-07 | |
PCT/CA1999/000724 WO2000007576A2 (en) | 1998-08-07 | 1999-08-06 | INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010651D0 NO20010651D0 (no) | 2001-02-07 |
NO20010651L true NO20010651L (no) | 2001-04-05 |
Family
ID=22252842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010651A NO20010651L (no) | 1998-08-07 | 2001-02-07 | Inhibering av type 3 3<alfa>-hydroxysteroiddehydrogenase |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1102582A2 (es) |
JP (1) | JP2002522380A (es) |
CN (1) | CN1322130A (es) |
AR (1) | AR021757A1 (es) |
AU (1) | AU5144999A (es) |
CA (1) | CA2339368A1 (es) |
ID (1) | ID28791A (es) |
NO (1) | NO20010651L (es) |
WO (1) | WO2000007576A2 (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
EP1321146A3 (en) * | 1998-03-11 | 2004-06-02 | Endorecherche Inc. | Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
US6891953B1 (en) | 2000-06-27 | 2005-05-10 | Microsoft Corporation | Method and system for binding enhanced software features to a persona |
US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
US6995278B2 (en) | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
CA2430100A1 (en) * | 2000-11-27 | 2002-05-30 | Entremed, Inc. | Antiangiogenic agents |
US6710037B2 (en) * | 2001-05-01 | 2004-03-23 | Schering Corporation | Method of treating androgen-dependent disorders |
DE60239207D1 (de) * | 2001-08-10 | 2011-03-31 | Takeda Pharmaceutical | Gnrh-agonistische kombinationsmittel |
EP1666033B1 (en) * | 2001-11-29 | 2008-12-31 | GTX, Inc. | Prevention and treatment of androgen-deprivation induced osteoporosis |
US7524866B2 (en) | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
JP2007529426A (ja) | 2004-03-12 | 2007-10-25 | エントレメッド インコーポレイテッド | 抗血管新生薬 |
DE102004032674A1 (de) * | 2004-07-02 | 2006-01-26 | Schering Ag | Neue 2-substituierte Estra-1,3,5(10)-trien-17-one als Inhibitoren der 17β-Hydroxysteroiddehydrogenase Typ 1 |
US7419972B2 (en) | 2004-07-02 | 2008-09-02 | Schering Ag | 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
CA2646065C (en) | 2006-03-20 | 2014-01-14 | Entremed, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
US9284345B2 (en) * | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
EP2181990B1 (en) * | 2007-08-31 | 2012-08-08 | Astellas Pharma Inc. | Piperidine derivative |
CN101698834B (zh) * | 2009-09-08 | 2012-05-23 | 北京利德曼生化股份有限公司 | 3α-羟基类固醇脱氢酶及其核苷酸序列、重组载体、重组宿主细胞和试剂盒 |
JP6196302B2 (ja) | 2012-07-10 | 2017-09-13 | バイエル・ファルマ・アクティエンゲゼルシャフト | 3−置換エストラ−1,3,5(10),16−テトラエン誘導体、その調製法、これらを含む医薬製剤および医薬を調製するためのその使用 |
KR20150118153A (ko) * | 2013-02-21 | 2015-10-21 | 바이엘 파마 악티엔게젤샤프트 | 17.베타.-히드록시스테로이드 데히드로게나제 (akr1 c3)의 억제를 위한 에스트라-1,3,5(10),16-테트라엔-3-카르복스아미드 |
CN104873525A (zh) * | 2014-02-27 | 2015-09-02 | 天津药物研究院 | 一种11β-羟基类固醇脱氢酶抑制剂及其药用组合物和用途 |
CN104873520A (zh) * | 2014-02-27 | 2015-09-02 | 天津药物研究院 | 一种11β-羟基类固醇脱氢酶抑制剂、药用组合物及其用途 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3562260A (en) * | 1965-08-23 | 1971-02-09 | Ormonoterapia Richter Spa | 2-carbonyl-estratrienes and method of their preparation |
US4340602A (en) * | 1978-10-18 | 1982-07-20 | Wayne State University | Compositions inhibiting estrogen sulfotransferase activity |
EP0117117A1 (en) * | 1983-02-22 | 1984-08-29 | Joachim Georg Liehr | Improvements in or relating to the treatment of estrogen deficiency conditions |
US4568673A (en) * | 1984-03-20 | 1986-02-04 | Wayne State University | Compositions inhibiting murine MXT ductal carcinoma |
US5504074A (en) * | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
CN1429104A (zh) * | 1998-03-11 | 2003-07-09 | 内部研究股份有限公司 | 5型和3型17β-羟基类固醇脱氢酶的抑制剂及其用法 |
-
1999
- 1999-08-06 CA CA002339368A patent/CA2339368A1/en not_active Abandoned
- 1999-08-06 ID IDW20010531A patent/ID28791A/id unknown
- 1999-08-06 EP EP99936218A patent/EP1102582A2/en not_active Withdrawn
- 1999-08-06 AU AU51449/99A patent/AU5144999A/en not_active Abandoned
- 1999-08-06 CN CN99811739A patent/CN1322130A/zh active Pending
- 1999-08-06 AR ARP990103961A patent/AR021757A1/es unknown
- 1999-08-06 WO PCT/CA1999/000724 patent/WO2000007576A2/en not_active Application Discontinuation
- 1999-08-06 JP JP2000563261A patent/JP2002522380A/ja active Pending
-
2001
- 2001-02-07 NO NO20010651A patent/NO20010651L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR021757A1 (es) | 2002-08-07 |
WO2000007576A3 (en) | 2000-03-30 |
EP1102582A2 (en) | 2001-05-30 |
CA2339368A1 (en) | 2000-02-17 |
WO2000007576A2 (en) | 2000-02-17 |
NO20010651D0 (no) | 2001-02-07 |
CN1322130A (zh) | 2001-11-14 |
JP2002522380A (ja) | 2002-07-23 |
AU5144999A (en) | 2000-02-28 |
ID28791A (id) | 2001-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20010651L (no) | Inhibering av type 3 3<alfa>-hydroxysteroiddehydrogenase | |
LV12316A (lv) | 16-aizvietoti 4-azoandrostani ka 5-alfa-reduktazes izozima 1 inhibitori | |
BR9908592A (pt) | Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit | |
DE69329240D1 (de) | 17-ether und thioether von 4-aza-steroiden | |
EA200000220A1 (ru) | Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы | |
DE69329149T2 (de) | 4-azasteroide als 5-alpha-reduktase | |
TR200002224T2 (tr) | Matris-bozucu metalloproteinasları inhibe eden sülfonilamino türevleri. | |
DE60309667D1 (de) | Biphenylderivate und ihre verwendung als antiandrogene | |
HU9501411D0 (en) | Pyran-2-one- and 5,6-dihydro-pyran-2-one derivatives for treating hiv- and other retrovirus infections | |
IS2012B (is) | Kínólín og kínasólín efnasambönd nytsamleg í meðferð, einkum til að meðhöndla góðkynja vefjaauka í blöðruhálskirtli | |
EA200100571A1 (ru) | Комбинированный способ лечебного воздействия, включающий применение лучевой терапии и ингибитора циклооксигеназы-2(cox-2) для лечения неоплазии | |
EP0646007A4 (es) | ||
DE69326008D1 (de) | 17-amino-substituierte 4-azasteroide als 5-alpha-reductase inhibitoren | |
DE69417925D1 (de) | 7-substituierte-4-aza-steroid-derivate als 5-alpha-reductase-hemmer | |
MXPA03002495A (es) | Proceso para preparacion de compuestos de n-(fenil sustituido)-3-alquil, aril- y heteroarilsulfonil-2-hidroxi-2-alquil- y haloalquilpropanamida. | |
DE69519728D1 (de) | 17 beta-aryl-4-aza-steroidderivate | |
ATE451107T1 (de) | 3-o-sulfamatsteroidderivate als hemmer von estronsulfatase | |
ES2182487T3 (es) | Procedimiento para el tratamiento de agua en circulacion procedente de una instalacion de laqueado. | |
NO983724D0 (no) | 17-<beta>-syklopropyl (amino/oksi)-4-aza-steroider som aktive inhibitorer av testosteron-5-<alfa>-reduktase og C17-20-lylase | |
DE69615046T2 (de) | 17-alkyl-7-substituierte-4-aza-steroidderivate | |
NO974801D0 (no) | Koldrengjöringspreparater basert på alkaner eller cykloalkaner og en organisk forbindelse omfattende en ketongruppe | |
TR200201167T2 (tr) | Sodyum-hidrojen değiştirici tip 1 önleyici kristalleri. | |
YU12295A (sh) | 16-supstituisani-4-aza-androstani inhibitori 5-alfa-reduktaze izozima 1 | |
IT1238011B (it) | Composizioni farmaceutiche a base di inibitori della riduttasi del hmg-coa per il trattamento della ipertrofia prostatica benigna. | |
UA33951A (uk) | Вольфрамат 1,2,3-бензотриазолію як інгібітор малоциклового корозійно-втомного руйнування металів в нейтральних середовищах |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |